No abstract

Introduction: Lichen planus is a chronic inflammatory, autoimmune, mucocutaneous disease of which the etiology is unknown. In Greek "lichen" means tree moss and "planus" means flat. It affects the skin, mucous membrane, nails, and hair. It is seen in 1 to 2% of the population. As the exact causative factor for oral lichen planus (OLP) is a matter of conflict, the failure to achieve proper or specific treatment for it may be reason for its incomplete regression. Corticosteroids are the mainstay of OLP but because of their adverse effects various other agents have been tried in the treatment of OLP. Aim:The aim of this review is to provide an update on the recent advances in the treatment of OLP.Results: An electronic search was conducted across Medline, Cochrane, Web of Science databases, and Google Scholar for the purpose of literature analysis on the mentioned topic. The studies were reviewed and compared. This article summarizes the recent advances in the treatment of OLP. Conclusion:Oral lichen planus has been an advanced researched oral potentially malignant disorder over the years. The newer treatment modalities have been considered to be beneficial with lesser amount of side effects than corticosteroids like amlexanox (AX), aloe vera gel, green tea, curcumin, propolis, and lycopene. Clinical significance:Oral lichen planus is seen in 1 to 2% of the population who come with varied symptoms or may be asymptomatic. Although treatment options are plenty, the mainstay of treatment is corticosteroids. However, the use of alternate therapeutics is proven to be effective with lesser side effects.

Objective: The objective of this study was to estimate the prevalence of ponticulus posticus among patients visiting JSS Dental College. Methods: The occurrence of ponticulus posticus and its forms were assessed in 435 lateral cephalograms (LCs) by 2 independent examiners. Data obtained were subjected to statistical analysis using Chi-square and κ analysis.